BlackRock Advisors’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
Sell
-16,895
Closed -$137K 3645
2013
Q2
$137K Buy
+16,895
New +$125K ﹤0.01% 2697

Other funds holding TSRX

BlackRock Advisors's TSRX Position: Q3 2013 in Review

BlackRock Advisors sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 16,895 shares — an estimated $137K sold.

BlackRock Advisors first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $137K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

  • BlackRock Advisors reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • BlackRock Advisors sold 16,895 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $137K.
  • BlackRock Advisors first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • BlackRock Advisors's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $137K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on BlackRock Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.